Latest Regulatory Framework News

The Foreign Investment Review Board has extended its deadline for approving Mayne Pharma's acquisition by Cosette Pharmaceuticals, maintaining the current transaction timetable for now.

EBOS Group Limited has updated its Dividend Reinvestment Plan rules, offering shareholders new ways to reinvest dividends into additional shares. The changes, effective immediately, provide greater flexibility and maintain board discretion over share issuance terms.

Hartshead Resources has been granted a two-year extension on Phase C of its UK North Sea Licence P2607, allowing more time to complete its work programme amid regulatory and supply chain delays.

Superior Resources Limited has lodged a transaction specific prospectus to offer 1,000 new shares at $0.01 each, enabling previously issued shares to be sold without further disclosure. The move addresses regulatory compliance while raising minimal funds.

Altair Minerals has formally opposed BHP’s plans to use its Olympic Domain Project area for infrastructure, leading to a court-ordered mediation ahead of a December hearing.

Nine Entertainment reported a resilient FY25 with strategic transformation gains, digital subscription growth, and a major capital return following the sale of its Domain stake. Leadership changes and regulatory challenges frame its path forward.

ALS Limited has responded to an ASX inquiry regarding the delayed lodgement of key disclosure documents related to performance rights granted to director Malcolm Deane, attributing the delay to human error and outlining steps to reinforce compliance.

Encounter Resources has completed the first tranche of its $25 million share placement, raising approximately $24.5 million to advance its mineral exploration projects. The second tranche, involving shares to a company director, awaits shareholder approval.

Tungsten Mining’s latest Scoping Study confirms Mt Mulgine as a globally significant tungsten and molybdenum project, underpinning a preferred 6 Mtpa development with robust economics and a clear path to production.

Challenger Limited has provided a detailed update on APRA’s proposed capital standards, highlighting enhanced capital strength and strategic growth opportunities in the life insurance sector.

ASF Group’s subsidiary has secured AUSTRAC registration as a Digital Currency Exchange, positioning itself for future digital asset opportunities while holding off on active trading.

Orthocell has completed its first Remplir™ surgical case in Hong Kong, marking a pivotal step in its Asian commercialisation strategy. The launch at the Hong Kong Orthopaedic Association Congress and partnership with MontsMed set the stage for broader regional growth.